DOCSLIB.ORG

Table of Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table of Contents INTRA-ARTICULAR DEPOT FORMING DRUG DELIVERY SYSTEM FOR OSTEOARTHRITIS Matthew Freddi, BSc (Hons) Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy May 2012 Abstract Osteoarthritis (OA) is a chronic degenerative disease of the joint. Current treatments for this disease (such as glucocorticoid steroids) aim to reduce pain and increase mobility. Intra-articular injection is used in OA as treatment can be targeted to affected joints only. There is currently a lack of sustained release formulations for intra-articular injection. The aim of this thesis was to produce and characterise an injectable intra- articular drug delivery system capable of providing delivery of the steroid dexamethasone phosphate (DXMP) over 3 months. This would be an injectable hydrogel that contains drug loaded nanoparticles. Initially two systems Pluronic F127 gels and polyelectrolyte complexes between hyaluronic acid (HA) and chitosan were investigated. The complexes between HA and chitosan were selected for the hydrogel portion of this system as they showed the greatest stability and promise in initial studies. To improve the polyelectrolyte complex properties a modified HA was synthesised. This modified polymer caused faster complex formation and produced stronger, more resilient complexes. DXMP was incorporated into poly(glycerol-adipate) (PGA) nanoparticles. A low but sufficient drug loading was achieved and particles were found to give a sustained drug release over 28 days. i Nanoparticles were found to be efficiently incorporated and well retained within complexes. Nanoparticles slightly improved complex formation and properties. Composites were able to be formulated into an injectable form. Drug release from directly loaded complexes was rapid. A full release profile was not determined from composites of nanoparticle loaded complexes; however, over 60% of the loaded drug was recovered after 56 days of release study. Dexamethasone crystals were also incorporated directly into complexes to investigate the necessity of the use of nanoparticles. This gave a sustained drug release over 90 days making this system worthy of further investigation. These results highlight the different responses of these systems using drugs with different hydrophobicities. ii Acknowledgments Firstly and most importantly I would like to thank my supervisors Dr. Martin Garnett and Dr. Snow Stolnik whose guidance and support were invaluable. I would also like to thank my AstraZeneca supervisors Simon Cruyws, Terry Woolley and Paul Gellert for their useful input. My thanks are also due to the EPSRC and AstraZeneca for funding and presenting me with this opportunity. I would like to thank the people who helped with my work during this project: Sanya Puri, Ahmed Abushrida and Mieke Heyde for help with the polymers; Bettina Wolf and Lloyd Hamilton for support with rheology. I would also like to thank the technical staff for their amazing work and dedication: Christy Grainger-Boultby, Paul Cooling, Teresa Marshall and Lee Hibbett. I would also like to acknowledge other students who have contributed to the results in this thesis: Fabrice Bayard who carried out the work on the PAA hydrogels in Chapter 3; Salome Gamble and Shy Lih Teo who both made contributions to some initial studies. My thanks are also due to Chris Grindon and Claudia Matz for emotional and administrative support as DTC project officer. Finally I would like to thank the other members of the Targeted Therapeutics DTC for their friendship and support, particularly Vicky Hutter, Klara Lovrics, Adnan Khan, Helen Angell and Gavin Hackett. Lastly I would like to thank all my friends and family for their constant support and love; especially my grandmother Sylvia Hope Butters who passed away in 2010 aged 94 and is greatly missed. iii Table of Contents Abstract ............................................................................................................ i Acknowledgments ......................................................................................... iii Table of Contents ........................................................................................... iv List of Figures .............................................................................................. xvi List of Tables ............................................................................................... xxi Abbreviations .............................................................................................. xxii CHAPTER 1 - INTRODUCTION ..................................................................... 1 1.1 General Introduction to Osteoarthritis ...................................................... 1 1.1.1 Introduction ....................................................................................... 1 1.1.2 Risk Factors ....................................................................................... 1 1.1.3 Prevalence .......................................................................................... 2 1.1.4 Impact ................................................................................................ 3 1.2 Synovial Joint Physiology ........................................................................ 3 1.2.1 General Structure ............................................................................... 4 1.2.2 Cartilage............................................................................................. 5 1.2.2.1 Extracellular matrix .................................................................... 5 1.2.2.2 Chondrocytes .............................................................................. 8 1.2.3 Synovial Membrane and Joint Capsule ............................................. 9 1.2.3.1 Synovial membrane .................................................................... 9 1.2.3.2 Joint capsule ............................................................................. 10 1.2.4 Synovial Fluid.................................................................................. 10 1.2.4.1 Hyaluronic acid ......................................................................... 11 1.2.4.2 Other constituents ..................................................................... 13 1.2.4.3 Functions .................................................................................. 14 iv 1.3 Disease Progression in Osteoarthritis ..................................................... 14 1.3.1 Early Osteoarthritis .......................................................................... 15 1.3.2 Progression to Clinical Osteoarthritis .............................................. 15 1.3.3 Cytokines ......................................................................................... 16 1.3.4 Enzymes........................................................................................... 17 1.3.5 Synovial Inflammation .................................................................... 19 1.3.6 Chondrocytes ................................................................................... 21 1.3.7 Reactive Oxygen Species ................................................................ 22 1.3.8 Synovial Fluid.................................................................................. 24 1.3.9 Osteophytes, Subchondral Bone Sclerosis and Capsular Fibrosis .. 26 1.3.9.1 Osteophytes .............................................................................. 26 1.3.9.2 Subchondral bone sclerosis ...................................................... 27 1.3.9.3 Capsular fibrosis ....................................................................... 28 1.3.10 Vicious Cycle ................................................................................ 28 1.4 Drug Treatments for Osteoarthritis ......................................................... 29 1.4.1 Current Treatments .......................................................................... 29 1.4.2 Intra-articular Delivery for Osteoarthritis ........................................ 30 1.4.2.1 Current treatments .................................................................... 30 1.4.2.2 Challenges for intra-articular delivery ...................................... 33 1.4.2.3 Drug delivery systems for intra-articular delivery.................... 34 1.4.3 Disease Modifying Drugs for Osteoarthritis ................................... 42 1.4.3.1 DMOAD potential of current treatments .................................. 42 1.4.3.2 Novel DMOADs ....................................................................... 43 1.4.3.3 DMOAD potential of other drugs ............................................. 45 1.5 Plan for Delivery System ........................................................................ 46 v 1.6 Introduction to Hydrogels and Injectable Hydrogels .............................. 47 1.6.1 Hydrogels......................................................................................... 47 1.6.2 Injectable Hydrogels ........................................................................ 48 1.6.3 Polyelectrolyte Complexes .............................................................. 49 1.6.3.1 Introduction to polyelectrolyte polymers ................................. 49 1.6.3.2 Polyelectrolyte complexation ................................................... 50 1.7 Introduction to Nanoparticle Drug Delivery Systems ............................ 52 1.7.1 General Introduction .......................................................................
Load more

Recommended publications
  • The ESGE Junior Platform
    Gynecol Surg (2009) 6 (Suppl 1):S33–S50 DOI 10.1007/s10397-009-0517-z ABSTRACTS The ESGE Junior Platform Techniques and Instrumentations in Laparoscopy Results: Total of 88 second-look operations were performed (63 after LM and 25 after OM). Intrauterine penetration was recorded in 32 JP1_01 cases (in 20 cases of LM and 12 patients with OM). Hysteroscopic finding was completely physiological in the majority of cases (77%), German residents’ experiences in gynaecological surgery in 5 cases (6%) intrauterine synechiae were present. During M. Stumpf, M. Klar, G. Gitsch, M. Runge, M. Foeldi laparoscopy we noticed a slight impression in the place of the uterine Department of Obstetrics and Gynaecology, University Medical suture in 6 patients (all after LM) and 1 utero-peritoneal fistula (after Center, Albert-Ludwigs-University, Freiburg, Germany OM with intrauterine penetration). Intraperitoneal adhesions were present in the total of 69 patients (78%): in 46 patients after LM (73%) Every German resident is taught in gynaecological surgery. Neverthe- and in 24 after OM (96%) (p=0.01). Adhesions were then graded less, a huge discrepancy of surgical skills among participants at the using a modified American Fertility Society (mAFS) scoring method. end of the residency can be observed. Gynaecological surgery is part The uterus mAFS score was applied. The mean mAFS score was 3,92 of the 5 year residency in obstetrics and gynaecology. The mandatory and 1,46 in the OM and LM group respectively (p=0.001). residency objectives are defined by the German Medical Association. Conclusion: In contrast with the physiological hysteroscopic finding A provided log book is mandatory to record achievements.
    [Show full text]
  • AAGL Practice Report: Practice Guidelines for Management of Intrauterine Synechiae
    Special Article AAGL Practice Report: Practice Guidelines for Management of Intrauterine Synechiae AAGL ADVANCING MINIMALLY INVASIVE GYNECOLOGY WORLDWIDE Background The search was not restricted to English language literature; committee members fluent in languages other than English re- Intrauterine adhesions (IUAs) have been recognized as viewed relevant articles and provided the committee with rel- a cause of secondary amenorrhea since the end of the 19th ative information translated into English. Because of the century [1], and in the mid-20th century, Asherman further paucity of data in this area, all published works were included described the eponymous condition occurring after preg- for the electronic database searches, and relevant articles not nancy [2]. The terms ‘‘Asherman syndrome’’ and IUAs are available in electronic sources (e.g., published before the be- often used interchangeably, although the syndrome requires ginning of electronic database commencement) were cross- the constellation of signs and symptoms (in this case, pain, referenced from hand-searched bibliographies and included menstrual disturbance, and subfertility in any combination) in the literature review. When necessary, authors were con- and the presence of IUAs [2]. The presence of IUAs in the tacted directly for clarification of points published. absence of symptoms may be best referred to as asymptom- atic IUAs or synechiae. Diagnosis Identification and Assessment of Evidence In women with suspected IUAs, physical examination usually fails to reveal abnormalities [3,4]. Blind transcervical This AAGL Practice Guideline was produced after elec- sounding of the uterus may reveal cervical obstruction at or tronic resources including Medline, PubMed, CINAHL, the near the level of the internal os [3].
    [Show full text]
  • National Institute for Health and Care Excellence
    IP1242 [IPG509] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of hysteroscopic metroplasty of a uterine septum for primary infertility or recurrent miscarriage In some women the uterus (womb) is divided into 2 halves by a thin wall of tissue, called a septum. This may affect fertility and increase the risk of miscarriage. In hysteroscopic metroplasty a thin tube with a camera on the end (a hysteroscope) is inserted into the vagina, through the cervix and into the womb. Instruments are passed through the hysteroscope into the womb and the septum is removed. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this interventional procedure (IP) overview to help members of the Interventional Procedures Advisory Committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This IP overview was prepared in April 2014 and updated in November 2014. Procedure name Hysteroscopic metroplasty of uterine septum in women with primary infertility or recurrent miscarriage Specialist societies Royal College of Obstetricians and Gynaecologists (RCOG) British Fertility Society. IP overview: hysteroscopic metroplasty of uterine septum in women with primary infertility or recurrent miscarriage 1 of 44 IP1242 [IPG509] Description Indications and current treatment A septate uterus is a type of congenital uterine anomaly, in which the inside of the uterus is divided by a muscular or fibrous wall, called the septum. The septum may be partial or complete, extending as far as the cervix.
    [Show full text]
  • Herestraat 49, B-3000 Leuven Yves Kremer, CU Saint-Luc, Av
    Editor | Prof. Dr. V. Bonhomme CO-Editors | Dr. Y. Kremer — Prof. Dr. M. Van de Velde ACTA ANAESTHESIOLOGICA JOURNAL OF THE BELGIAN SOCIETY OF ANESTHESIOLOGY, RESUSCITATION, PERIOPERATIVE MEDICINE AND PAIN MANAGEMENT (BeSARPP) BELGICA Indexed in EMBASE l EXCERPTA MEDICA ISSN: 2736-5239 Suppl. 1 202071 Master Theses www.besarpp.be Cover-1 -71/suppl.indd 1 12/01/2021 12:37 ACTA ANÆSTHESIOLOGICA BELGICA 2020 – 71 – Supplement 1 EDITORS Editor-in-chief : Vincent Bonhomme, CHU Liège, av. de l’Hôpital 1, B-4000 Liège Co-Editors : Marc Van de Velde, KU Leuven, Herestraat 49, B-3000 Leuven Yves Kremer, CU Saint-Luc, av. Hippocrate, B-1200 Woluwe-Saint-Lambert Associate Editors : Margaretha Breebaart, UZA, Wilrijkstraat 10, B-2650 Edegem Christian Verborgh, UZ Brussel, Laarbeeklaan 101, B-1090 Jette Fernande Lois, CHU Liège, av. de l’Hôpital 1, B-4000 Liège Annelies Moerman, UZ Gent, C. Heymanslaan 10, B-9000 Gent Mona Monemi, CU Saint-Luc, av. Hippocrate, B-1200 Woluwe-Saint-Lambert Steffen Rex, KU Leuven, Herestraat 49, B-3000 Leuven Editorial assistant Carine Vauchel Dpt of Anesthesia & ICM, CHU Liège, B-4000 Liège Phone: 32-4 321 6470; Email: [email protected] Administration secretaries MediCongress Charlotte Schaek and Astrid Dedrie Noorwegenstraat 49, B-9940 Evergem Phone : +32 9 218 85 85 ; Email : [email protected] Subscription The annual subscription includes 4 issues and supplements (if any). 4 issues 1 issue (+supplements) Belgium 40€ 110€ Other Countries 50€ 150€ BeSARPP account number : BE97 0018 1614 5649 - Swift GEBABEBB Publicity : Luc Foubert, treasurer, OLV Ziekenhuis Aalst, Moorselbaan 164, B-9300 Aalst, phone: +32 53 72 44 61 ; Email : [email protected] Responsible Editor : Prof.
    [Show full text]
  • Adhesion Prevention in Reproductive Surgery Special Interest Group Reproductive Surgery
    Adhesion prevention in Reproductive Surgery Special Interest Group Reproductive Surgery 3 July 2011 Stockholm, Sweden 7 Adhesion prevention in reproductive surgery Stockholm, Sweden 3 July 2011 Organised by Special Interest Group Reproductive Surgery Contents Course coordinators and target audience Page 5 Programme Page 7 Introduction to ESHRE Page 9 Speakers’ contributions Pathophysiology of adhesion formation – Timur Gürgan (Turkey) Page 17 Adhesion prevention in a laparoscopic mouse model – Maria Mercedes Binda (Belgium) Page 27 Adhesions and reproduction – Stephan Gordts (Belgium) Page 41 Adhesion prophylaxis in clinical routine: lessons learned from experimental models to clinical applications – Luciano Nardo (United Kingdom) Page 63 Postoperative intra uterine adhesions: why? – Pietro Gambadauro (Sweden) Page 75 Hysteroscopic treatment of Asherman syndrome – Tin‐Chiu Li (United Kingdom) Page 89 Prevention of postoperative intra uterine adhesions – Rudi Campo (Belgium) Page 111 Adhesion formation after ovarian drilling comparison of laparoscopy and fertiloscopy – Antoine Watrelot (France) Page 130 No postoperative adhesions anymore: fiction or reality? – Philippe Koninckx (Belgium) Page 137 Upcoming ESHRE Campus Courses Page 151 Notes Page 152 Page 3 of 159 Page 4 of 159 Course coordinators Marco Gergolet, Vassilios Tanos, Rudi Campo, Stephan Gordts Target audience Specialist gynaecologist, particularly those, involving in reproductive and endoscopic surgery Page 5 of 159 Page 6 of 159 Scientific programme 09.00 ‐ 09.30 Pathophysiology
    [Show full text]
  • Effects of Hyalobarrier Gel and Seprafilm in Preventing Peritendinous Adhesions Following Crush-Type Injury in a Rat Model
    EXPERIMENTAL STUDY Effects of Hyalobarrier gel and Seprafilm in preventing peritendinous adhesions following crush-type injury in a rat model 1 2 Emel Yurdakul Sıkar, M.D., Hasan Ediz Sıkar, M.D., 3 1 Hüsamettin Top, M.D., Ahmet Cemal Aygıt, M.D., 1Department of Plastic, Reconstructive and Aesthetic Surgery, Bağcılar Training and Research Hospital, İstanbul-Turkey 2Department of General Surgery, Kartal Dr. Lütfi Kirdar Training and Research Hospital, İstanbul-Turkey 3Department of Plastic, Reconstructive and Aesthetic Surgery, Trakya University Faculty of Medicine, Edirne-Turkey ABSTRACT BACKGROUND: In the present study, the aim was to evaluate the effects of Hyalobarrier gel (Anika Therapeutics S.r.l., Abano Terme, Italy) and Seprafilm adhesion barrier (Genzyme Corporation, Cambridge, MA, USA) in the prevention of peritendinous adhesions fol- lowing a crush-type injury. METHODS: Twenty five female Wistar Albino rats, weighing 230 to 270 g and 7 to 9 months of age were randomized into 5 groups. Group 1 was the control group, Group 2 comprised the Hyalobarrier gel group, Group 3 was made up of the Seprafilm-treated subjects, Group 4 was the tendon repair and Hyalobarrier gel group, and Group 5 was the tendon repair and Seprafilm group. Two gastrocnemius muscle tendons of each animal, a total of 50 tendons, were used. The animals were sacrificed with the administration of a high dose of anesthetic on postoperative day 40. Macroscopic evaluation of adhesions was classified by 2 blinded researchers according to Tang’s adhesion grading system. The number of fibroblasts and the density and formation of collagen fibers were noted for histopathological examination.
    [Show full text]
  • Advances, Retreats and Challenges in Adhesions Research
    ЭЛЕКТРОННЫЙ НАУЧНЫЙ ЖУРНАЛ «INNOVA» 2016 №1 (2) Innova-journal.ru 1 HUMANITARIAN SCIENCES ГУМАНИТАРНЫЕ НАУКИ ЭЛЕКТРОННЫЙ НАУЧНЫЙ ЖУРНАЛ «INNOVA» 2016 №1 (2) Innova-journal.ru Founder: Kursk State Medical University. Publisher: MedTestInfo LLC. Chair of Editoral Board: Victor Lazarenko – Doctor of Medical Sciences, Honoured Doctor of Russian Federation. Vice-Editor: Pavel Tkachenko – Doctor of Medical Sciences. Editor-in-Chief: Viacheslav Lipatov – Doctor of Medical Sciences. Technical Secretary: M. David Naimzada. Editorial Board: Daria Alontceva — Doctor of Physical and Mathematical Sciences, Ust-Kamenogorsk, Kazakhstan. Marina Nikolaevna Belogubova — Doctor of Sociological Sciences, Moscow, Russia. Konstantin Enkoyan — Doctor of Medical and Biological Sciences, Erevan, Armenia. Irina Frishman — Doctor of Pedagogical Sciences, Moscow, Russia. Karl-Iosef Gundermann — Doctor of Sciences, Shetcin, Poland. Vladimir Ivanov — Doctor of Biological Sciences, Kursk, Rossia. Sisakian Khmaiak — Doctor of Medical Sciences Erevan, Armenia. Anatolii Lyzikov – Doctor of Medical Sciences , Gomel, Belorus. Viorel Naku — Doctor of Science, Kishinev, Moldova. Leonid Prokopenko — Doctor of Medical Sciences, Kursk, Russia. David Wiseman — Philosophy Doctor, Dallas, USA. Liu Hung-Wen — Philosophy Doctor, Harbin, China. Editorial team: Elena Budko - Doctor of Pharmacy, Kursk, Russia. Tatiana Vasilenko - Doctor of Psychology, Kursk, Russia. Vasiliy Gavrilyuk - Doctor of Medical Sciences, Kursk, Russia. Vitaliy Zotov - Doctor of Social Sciences, Kursk, Russia. Alexander Konichenko - Doctor of Technical Sciences, Kursk, Russia. Elena Kravtsova - Doctor of Historical Sciences, Kursk, Russia. Alexey Loktionov - Doctor of Medical Sciences, Kursk, Russia. Galina Mal - Doctor of Medical Sciences, Kursk, Russia. Povetkin Sergey - Doctor of Medical Sciences, Kursk, Russia. Irina Privalova- Doctor of Biological Sciences, Kursk, Russia. Maria Solodilova - Doctor of Biological Sciences, Kursk, Russia. Irina Shamara - Candidate of Philological Sciences, Kursk, Russia.
    [Show full text]
  • Anti-Adhesion Therapy Following Operative Hysteroscopy for Treatment of Female Subfertility (Review)
    Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility (Review) Bosteels J, Weyers S, Kasius J, Broekmans FJ, Mol BWJ, D’Hooghe TM This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2015, Issue 11 http://www.thecochranelibrary.com For Preview Only Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility (Review) Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . ..... 4 BACKGROUND .................................... 7 OBJECTIVES ..................................... 9 METHODS ...................................... 9 RESULTS....................................... 13 Figure1. ..................................... 15 Figure2. ..................................... 17 Figure3. ..................................... 18 Figure4. ..................................... 27 Figure5. ..................................... 28 Figure6. ..................................... 30 ADDITIONALSUMMARYOFFINDINGS . 30 DISCUSSION ..................................... 33 Figure7. ..................................... 34 AUTHORS’CONCLUSIONS . 36 ACKNOWLEDGEMENTS . 36 REFERENCES ..................................... 37 CHARACTERISTICSOFSTUDIES . 42 DATAANDANALYSES. 82 Analysis 1.1. Comparison 1 Inserted
    [Show full text]
  • Abdominal Adhesions: Current and Novel Therapies
    Journal of Surgical Research 165, 91–111 (2011) doi:10.1016/j.jss.2009.09.015 RESEARCH REVIEW Abdominal Adhesions: Current and Novel Therapies Brian C. Ward, Ph.D.,*,† and Alyssa Panitch, Ph.D.*,1 *Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana; and †Indiana University School of Medicine, Indianapolis, Indiana Submitted for publication July 13, 2009 An adhesion occurs when two tissues that normally Abdominal adhesions place a tremendous burden on freely move past each other attach via a fibrous bridge. public health. Adhesions develop after nearly every ab- Abdominal adhesions place a tremendous clinical and dominal surgery. Multiple studies cite that of patients financial burden on public health. Adhesions develop who have abdominal surgery, 93% will have adhesions after nearly every abdominal surgery, commonly caus- [3, 4]. Many of these adhesions require a second opera- ing female infertility, chronic pelvic pain, and, most tion known as adhesiolysis to break the adhesion. A frequently, small bowel obstruction. A National Hospi- comprehensive study of inpatient care and expendi- tal Discharge Survey of hospitalizations between 1998 tures associated with adhesiolysis procedures in the and 2002 reported that 18.1% of hospitalizations were United States was conducted in 1994. This study found related to abdominal adhesions annually accounting for 948,000 days of inpatient care at an estimated cost that adhesiolysis accounted for 303,836 hospitaliza- of $1.18 billion. tions (1% of the hospitalizations in the United States), This review discusses the current or proposed thera- 846,415 days of inpatient care, and $1.33 billion in hos- pies for abdominal adhesions.
    [Show full text]
  • Studies on the Effectiveness of Endoscopic Surgery in Reproductive Medicine
    UvA-DARE (Digital Academic Repository) Studies on the effectiveness of endoscopic surgery in reproductive medicine Bosteels, J.J.A. Publication date 2014 Document Version Final published version Link to publication Citation for published version (APA): Bosteels, J. J. A. (2014). Studies on the effectiveness of endoscopic surgery in reproductive medicine. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:28 Sep 2021 UNIVERSITY OF AMSTERDAM DISSERTATION Jan Bosteels Studies on The Efffectiveness of Endoscopic Surgery in Reproductive Medicine STUDIES ON THE EFFECTIVENESS OF ENDOSCOPIC SURGERY IN REPRODUCTIVE MEDICINE Jan Bosteels Studies on the effectiveness of endoscopic surgery in reproductive medicine Thesis, University of Amsterdam, the Netherlands Paranimfen: Wim Laurens, Philippe Delattin Lay out: Jan Bosteels Cover design: Coördesign, Leiden Cover illustration: ’ICSI revisited: Independent and Critically Summarized Investigation’ ISBN 978 90 5629 755 8 NUR 870 © J.
    [Show full text]
  • Efficacy of Barriers and Hypoxia-Inducible Factor Inhibitors
    Journal of Minimally Invasive Gynecology (2007) 14, 591–599 Efficacy of barriers and hypoxia-inducible factor inhibitors to prevent CO2 pneumoperitoneum-enhanced adhesions in a laparoscopic mouse model Maria Mercedes Binda, PhD, Carlos Roger Molinas, MD, PhD, Adriana Bastidas, MD, Marc Jansen, MD, and Philippe Robert Koninckx, MD, PhD From the Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium (Drs. Binda, Bastidas, and Koninckx); the Centre for Gynaecological Endoscopy (Cendogyn), Centro Médico La Costa, Asunción, Paraguay (Dr. Molinas); and Department of Surgery, University Clinic, RWTH Aachen, Germany (Dr. Jansen). KEYWORDS: Abstract Barriers; STUDY OBJECTIVE: To investigate the effects of hypoxia-inducible factor (HIF) inhibitors, flotation Flotation; agents, barriers, and a surfactant on pneumoperitoneum-enhanced adhesions in a laparoscopic mouse HIF; model. Hypoxia; DESIGN: Prospective randomized trial (Canadian Task Force classification I). Intraperitoneal SETTING: Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Catholic adhesion formation; University of Leuven. Laparoscopy; SUBJECTS: One hundred fourteen female BALB/c mice. Pneumoperitoneum; INTERVENTIONS: Adhesions were induced during laparoscopy in BALB/c female mice. Pneumo- Prevention; peritoneum was maintained for 60 minutes with humidified CO2. In 3 experiments the effects of HIF Surfactant inhibitors such as 17-allylamino 17-demethoxygeldanamycin, radicicol, rapamycin, and wortmanin, flotation agents such as Hyskon and carboxymethylcellulose, barriers such as Hyalobarrier gel and SprayGel, and surfactant such as phospholipids were evaluated. MEASUREMENTS AND MAIN RESULTS: Adhesions were scored after 7 days during laparotomy. Adhesion formation decreased with the administration of wortmannin (p Ͻ.01), phospholipids (p Ͻ.01), Hyalobarrier Gel (p Ͻ.01), and SprayGel (p Ͻ.01).
    [Show full text]
  • Effects of Ovarian Surgery on Ovarian Reserve and Fertility
    From Department of Oncology-Pathology Karolinska Institutet, Stockholm, Sweden EFFECTS OF OVARIAN SURGERY ON OVARIAN RESERVE AND FERTILITY Tekla Lind Stockholm 2015 All previously published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by E-PRINT © Tekla Lind, 2015 ISBN 978-91 -7549 -813 -3 Effect of ovarian surgery on ovarian reserve and fertility THESIS FOR DOCTORAL DEGREE (Ph.D.) To be publicly defended at Aulan Södersjukhuset. Friday 27th March 2015, 9.00 am By Tekla Lind Principal Supervisor: Opponent: Kenny Rodriguez-Wallberg, MD PhD Associate Torbjörn Hillensjö, MD PhD Associate Professor Professor Sahlgrenska Akademin Karolinska Institutet Department of Clinical Sciences Department of Oncology- Pathology Division of Obstetrics and Gynecology Karolinska University Hospital, Obstetrics & Gynecology and Reproductive Medicine Examination Board: Co-supervisor(s): Matts Olovsson, MD PhD Professor Uppsala University Margareta Hammarström, MD PhD Professor Department of Women and Children’s Health Karolinska Institutet Division of Obstetrics and Gynecology Department of Clinical Science and Education, Södersjukhuset, Britt-Marie Landgren, MD PhD Professor Emerita Division of Obstetrics and Gynecology Karolinska Institutet Department of Clinical Science, Intervention and Claudia Lampic, PhD Associate Professor Technology CLINTEC Karolinska Institutet Division of Obstetrics and Gynecology Department of Neurobiology, Care sciences and Britt Friberg, MD PhD Associate Professor Society, Lunds University Division of Nursing Department of Clinical Sciences, Malmö Jan I. Olofsson, MD PhD Associate Professor Division of Reproductive Medicine Karolinska University Hospital Reproductive Medicine Department of Obstetrics and Gynecology To the women who participated in these studies ABSTRACT The objective of this thesis was to investigate short- and long-term effects of ovarian surgery on the ovarian reserve of women of reproductive age.
    [Show full text]